Open in interactive viewer → charts, metric popovers & call review

American Vanguard: $24 Million of Equity, One Quarter to Justify It

AVD cut full-year guidance and now needs roughly the entire year's EBITDA to land in Q4 — with gross leverage at 6.5x against a 6.7x covenant maximum.
AVD · Earnings Call · 2026-11-09

A Cut That Was Supposed to Be Impossible

Three months ago, on the second-quarter call, Douglas Kaye was asked directly about the confidence level behind the order book and the full-year forecast. His answer was unambiguous: “So we still feel comfortable with our forecast, and we still feel that is very achievable.” — Douglas A. Kaye, Chief Executive Officer · 2026-08-10 On November 9, third-quarter revenue fell 9% to $108 million and adjusted EBITDA came in at essentially breakeven, down $8.3 million year over year. The guidance was cut on both lines: “We now expect full year revenue to be in the range of $500 million to $530 million, down from our prior range of $530 million to $550 million.” — Douglas Kaye, Chief Executive Officer · 2026-11-09 Adjusted EBITDA guidance went from $44–48 million to $36–40 million. The tape had already voted. American Vanguard's shares are down 72.5% over the last ninety trading days, from a July 7 close of $2.97 to roughly $0.81 — a market capitalization of about $24 million. That is not a company being repriced on a guidance miss; that is an equity being repriced as an option.

The Covenant Is the Whole Story

For debt covenant purposes, under our first lien term loan, our gross leverage ratio was 6.5x at the end of the quarter against a covenant maximum of 6.7x.

Matthew Horwath, Chief Financial Officer · 2026-11-09
Twenty basis points of headroom. Against that sits $267.7 million of total debt and $183.8 million of net debt, with the equity valued at barely a seventh of the net debt it sits behind. The multi-year shape is ugly: effective net cash has slid from roughly negative $19 million in 2017 to negative $224 million today, and interest coverage has gone from comfortably double-digit to negative 1.0x. Liabilities sit at 71.5% of assets and rising. So do the arithmetic on the guide. If full-year adjusted EBITDA is $36–40 million and the fourth quarter alone is guided to $21 million, then nine months of 2026 delivered somewhere in the mid-teens — and the entire year depends on one quarter landing. Management is explicit that the fourth quarter is historically its best, and that last year's comparable was polluted by an $11 million-plus upfront royalty that flattered both sales and EBITDA. Beating that comp by 25% is a genuinely aggressive ask. And the liquidity crutch is shrinking at the same time: fourth-quarter prepayment and early-pay collections are guided to $45 million versus roughly $55 million a year ago. When Jeff Bronchick asked how much of the fourth quarter was already booked by November 9, the answer was refreshingly honest and not at all comforting:

I wish I could say it was baked. That's not the way it works. There's a lot of work to be done in the fourth quarter.

Douglas Kaye, Chief Executive Officer · 2026-11-09

What Actually Broke: Weather, Diesel, and a Farm Economy on Federal Aid

This is not a story about execution failure, and management's defense is largely supported by the numbers it can control. It is a story about two exogenous shocks arriving simultaneously. The first is El Niño, which Kaye says is “materially impacting our business” — Douglas Kaye, Chief Executive Officer · 2026-11-09 — drought on the Pacific side of Central America, excess rain on the Atlantic side, generic competition in Mexico, and copper-driven fungicide pricing plus political uncertainty in Brazil. International sales fell 17% in the quarter. That weather theme is not unique to AVD; it echoed across agricultural and consumer reporters this season, including a global El Niño cluster flagged at the top of the market's keyword table for the prior quarter. The second shock is the one that actually broke the margin story. Diesel climbed over 40% in the third quarter alone and over 80% year-to-date, driving transportation costs into a 250-basis-point hit to gross margin — freight alone. Gross margin fell to 24.2% from 28.7%, extending a long deterioration from the 42.6% peak in 2017 (29.7% trailing). The cruel symmetry: the Los Angeles plant closure delivered its promised $4 million a year of savings, but the company says those savings were "more than offset" by freight. A self-help program was neutralized by a cost line management does not set. That is also a shared market condition — diesel fuel and high fuel costs surfaced across trucking, airline, and rail reporters in the same window — but AVD's exposure is unusually levered because its volumes are already thin. Layered on top is a farm economy running on federal support: U.S. government aid is expected to exceed 40% of total net farm income this year, versus 25% last year and an 18–19% thirty-year average (U.S. government aid). That is why distributors buy as-needed and carry lean inventory regardless of how good the product is.

What Management Stopped Saying — and Started Doing

The quiet retreat is the most revealing part of this call. For over a year the company anchored investors to a mid-teens EBITDA margin ambition and a $100 million new-product revenue pipeline. A year ago Kaye was explicit that the payoff was distant: “We're not going to see fruition on those new product sales until materially until starting to '28.” — Douglas Kaye, Chief Executive Officer · 2025-11-10 On this call the mid-teens target has dissolved into a humbler formulation — moving the EBITDA margin "into double digits as soon as possible" — while the $600 million revenue run-rate ambition was simply pushed out to the back half of 2028. The goalposts did not move much; the confidence did. What did change is capital allocation. After a year of saying industry consolidation would hand it the chance to buy brands off the majors again, AVD actually did it: four U.S. branded registrations from Syngenta plus a distribution agreement with Sipcam Agro, for $5 million upfront and $4.5 million deferred — $9.5 million total against a claimed $15–20 million of annualized revenue. Kaye framed it as a return to identity: “going back to product acquisitions is the DNA of the company going back from a long time.” — Douglas Kaye, Chief Executive Officer · 2026-11-09 That is the strategy he told investors to expect a year ago — “we see a strong opportunity to get back to what we were doing 10 years ago, which was buying a portfolio of products off the basics when they go through these consolidation period.” — Douglas Kaye, Chief Executive Officer · 2025-11-10 It is now happening, but at a scale that is symbolic rather than transformational. The operating evidence for the other leg is mixed-but-real: prepayments up 44% year over year, cash up $40 million sequentially to $84 million, inventory down $4.9 million, and the new products — including the corn insecticide Duro LQ — landing in the current quarter, with Kaye confirming “They're hitting now.” — Douglas Kaye, Chief Executive Officer · 2026-11-09

The verdict. AVD at 0.2x revenue and 0.5x gross profit is priced as if the covenant breaks. The bull case is narrow but specific: cost initiatives and U.S. crop volume are working, the freight shock is cyclical rather than structural, and a single strong annualized revenue quarter plus prepay season resets leverage below the tripwire and opens a refinancing window. The bear case is simpler: one bad quarter against 20 basis points of covenant headroom, with a $24 million equity riding on it. Only one analyst asked a question on this call. That is the most honest sell-side rating in the deck.